FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Medtronic plc Stock AnalysisComprehensive stock analysis for Medtronic plc (MDT) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisMDT
MDT
Medtronic plc
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MDT
Home🔹Stocks🔹Medtronic plc

Medtronic plc

🇺🇸MDT•NYSE

Medtronic plc

🇺🇸MDT•NYSE
Market cap
$116.43B
Sentiment

Your view on MDT

Mkt Cap
$116.43B
Sentiment
Your view
MDT
Medtronic plc
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
MDT
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Medtronic plc

Industry
Medical - Devices
Sector
Healthcare
CEO
Geoffrey Straub Martha
Headquarters
20 On Hatch, Galway, IE
Industry
Medical - Devices
Sector
Healthcare
CEO
Geoffrey Straub Martha
Headquarters
20 On Hatch, Galway, IE
Description

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.

Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.

It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products.

The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease.

Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments.

It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain.

The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Medtronic plc, and the rating behind it. MDT last traded at $90.96, 22.2× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Medtronic plc. Starting points for Medtronic plc: P/E 22.2, EPS $4.09, beta 0.57 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Medtronic plc. Medtronic plc paid $2.85 per share over the last year — a 3.1% yield at the current $90.96 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Medtronic plc. Trailing twelve-month EPS for Medtronic plc stands at $4.09. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Medtronic plc. Medtronic plc has reported as a listed company since 1973. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Medtronic plc valued side by side against its closest peers. Medtronic plc is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Medtronic plc, and how their positions are changing. At a $116.43B market value, institutional positions materially move Medtronic plc's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Medtronic plc executives and directors. Shares of Medtronic plc have traded between $79.29 and $102.48 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Medtronic plc. Medtronic plc is a $116.43B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Medtronic plc. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Medtronic plc. Coverage tracks Medtronic plc within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • BMY — Bristol-Myers Squibb Company
  • BSX — Boston Scientific Corporation
  • CVS — CVS Health Corporation
  • EW — Edwards Lifesciences Corporation
  • GSK — GSK plc
  • HCA — HCA Healthcare, Inc.
  • MCK — McKesson Corporation
  • SNY — Sanofi

More Medical - Devices companies

  • AMBBY — Ambu A/S
  • AMBFF — Ambu A/S
  • AMIX — Autonomix Medical, Inc. Common Stock
  • AORT — Artivion, Inc.
  • AQQRF — Aquarius Surgical Technologies Inc.
  • ARAY — Accuray Incorporated
  • ARMM — Armm Inc.
  • ARX.AX — Aroa Biosurgery Limited
  • ASAPF — Aurora Spine Corporation
  • ASG.V — Aurora Spine Corporation
  • ASTI.CN — Aquarius Surgical Technologies Inc.
  • AT1.AX — Atomo Diagnostics Limited

ETFs holding Medtronic plc

  • ABEQ — Absolute Select Value ETF (5.58%)
  • HHL.TO — Harvest Healthcare Leaders Income ETF (5.00%)
  • CAMX — Cambiar Aggressive Value ETF (4.03%)
  • MAVF — Matrix Advisors Value ETF (3.73%)
  • DIVP — Cullen Enhanced Equity Income ETF (3.40%)
  • AIVL — WisdomTree U.S. AI Enhanced Value Fund (3.39%)
  • ELCV — Eventide High Dividend ETF (3.32%)
  • AGNG — Global X - Aging Population ETF (3.08%)

News

Latest Market News